Optimal drug pricing, limited use conditions and stratified net benefits for Markov models of disease progression
Year of publication: |
2008
|
---|---|
Authors: | Zaric, Gregory S. |
Published in: |
Health economics. - Chichester : Wiley-Blackwell, ISSN 1057-9230, ZDB-ID 1135838-5. - Vol. 17.2008, 11, p. 1277-1294
|
Subject: | Arzneimittel | Pharmaceuticals | Preismanagement | Pricing strategy | Zahlungsbereitschaftsanalyse | Willingness to pay | Theorie | Theory |
-
Value-based differential pricing : efficient prices for drugs in a global context
Danzon, Patricia Munch, (2015)
-
Wettstein, Dominik J., (2020)
-
Price discrimination and investment incentives
Alexandrov, Alexei, (2012)
- More ...
-
Somé, Nibene H., (2020)
-
Care‐coordination : Gain‐sharing Agreements in Bundled Payment Models
Ghamat, Salar, (2021)
-
Critchley, Gregory J., (2019)
- More ...